Literature DB >> 8202483

A cell cycle-regulated inhibitor of cyclin-dependent kinases.

L Hengst1, V Dulic, J M Slingerland, E Lees, S I Reed.   

Abstract

Cyclin-dependent kinases (Cdks) previously have been shown to drive the major cell cycle transitions in eukaryotic organisms ranging from yeast to humans. We report here the identification of a 28-kDa protein, p28Ick (inhibitor of cyclin-dependent kinase), that binds to and inhibits the kinase activity of preformed Cdk/cyclin complexes from human cells. p28 inhibitory activity fluctuates during the cell cycle with maximal levels in G1 and accumulates in G1- and G0-arrested cells. These results suggest that control of the G1/S transition may be influenced by a family of Cdk inhibitors that include p28Ick and the recently described inhibitors p21Cip1/Waf1/Cap20 and p16Ink4.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8202483      PMCID: PMC43980          DOI: 10.1073/pnas.91.12.5291

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

Review 1.  The role of p34 kinases in the G1 to S-phase transition.

Authors:  S I Reed
Journal:  Annu Rev Cell Biol       Date:  1992

Review 2.  Dominoes and clocks: the union of two views of the cell cycle.

Authors:  A W Murray; M W Kirschner
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

Review 3.  Mitotic control.

Authors:  J L Maller
Journal:  Curr Opin Cell Biol       Date:  1991-04       Impact factor: 8.382

4.  An inhibitor of p34CDC28 protein kinase activity from Saccharomyces cerevisiae.

Authors:  M D Mendenhall
Journal:  Science       Date:  1993-01-08       Impact factor: 47.728

5.  Synchronization of tumor and normal cells from G1 to multiple cell cycles by lovastatin.

Authors:  K Keyomarsi; L Sandoval; V Band; A B Pardee
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

6.  Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.

Authors:  A Koff; A Giordano; D Desai; K Yamashita; J W Harper; S Elledge; T Nishimoto; D O Morgan; B R Franza; J M Roberts
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

7.  Association of human cyclin E with a periodic G1-S phase protein kinase.

Authors:  V Dulić; E Lees; S I Reed
Journal:  Science       Date:  1992-09-25       Impact factor: 47.728

8.  Cyclin E/cdk2 and cyclin A/cdk2 kinases associate with p107 and E2F in a temporally distinct manner.

Authors:  E Lees; B Faha; V Dulic; S I Reed; E Harlow
Journal:  Genes Dev       Date:  1992-10       Impact factor: 11.361

9.  Identification of G1 kinase activity for cdk6, a novel cyclin D partner.

Authors:  M Meyerson; E Harlow
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

10.  Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15.

Authors:  Y Gu; J Rosenblatt; D O Morgan
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  77 in total

1.  The p27/Kip1 locus shows no loss of heterozygosity in human pituitary adenomas.

Authors:  J C Wilson; J J Zhu; P M Black
Journal:  J Neurooncol       Date:  1999-08       Impact factor: 4.130

2.  Circadian variation in the expression of cell-cycle proteins in human oral epithelium.

Authors:  G A Bjarnason; R C Jordan; R B Sothern
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

3.  Overexpression of p27(KIP1) induced cell cycle arrest in G(1) phase and subsequent apoptosis in HCC-9204 cell line.

Authors:  Jiang Li; Xin-Ke Yang; Xin-Xin Yu; Meng-Liang Ge; Wen-Liang Wang; Jie Zhang; Yun-De Hou
Journal:  World J Gastroenterol       Date:  2000-08       Impact factor: 5.742

Review 4.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

5.  The CRM1 nuclear export protein in normal development and disease.

Authors:  Kevin T Nguyen; Michael P Holloway; Rachel A Altura
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

6.  p27Kip1 inhibits the cell cycle through non-canonical G1/S phase-specific gatekeeper mechanism.

Authors:  Savitha S Sharma; Le Ma; W Jackson Pledger
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

7.  p27Kip1 acts downstream of N-cadherin-mediated cell adhesion to promote myogenesis beyond cell cycle regulation.

Authors:  Graziella Messina; Cristiana Blasi; Severina Anna La Rocca; Monica Pompili; Attilio Calconi; Milena Grossi
Journal:  Mol Biol Cell       Date:  2005-01-12       Impact factor: 4.138

8.  Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.

Authors:  J Vlach; S Hennecke; B Amati
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

9.  Effect of p27(KIP1) on cell cycle and apoptosis in gastric cancer cells.

Authors:  Jian-Yong Zheng; Wei-Zhong Wang; Kai-Zong Li; Wen-Xian Guan; Wei Yan
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 10.  p27 deregulation in breast cancer: prognostic significance and implications for therapy.

Authors:  A Alkarain; R Jordan; J Slingerland
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.